Your portal to stay connected with the pharma and biopharma industry
Your portal to stay connected with the pharma and biopharma industry
Your portal to stay connected with the pharma and biopharma industry
BD (Becton, Dickinson, and Company) is a leading global medical technology company that focuses on advancing healthcare through improved medical
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
Chester Medical has ploughed just under £500,000 CAPEX investment as it continues to grow. With Jenny Dixon who joined Chester
Aptar Pharma, is a pharmaceutical leader in the manufacturing and development of drug delivery systems and solutions. They have launched
Explore Drug Solutions Podcast lates podcast as it looks back at the challenges and innovation highlights in 2022 for oral solid dosage forms, reviewing industry experts’ takes on factors driving the evolution of OSD forms and much more.
PackagingInsights speaks to industry experts about the key trends in anti-counterfeit and ecological products. They also call for less flux and flow in pharmaceutical packaging legislation based on frustrations from the many changes in laws this year.
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
Scientists, Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D. from Shirley Ryan AbilityLab, and John Rogers, Ph.D. from Northwestern University,
Pfizer’s nasal spray, ZAVZPRET™, which treats migraines, has gained approval from the FDA. It is the first and only calcitonin
Aptar Pharma is launching APF Futurity, its first metal-free, designed-for-recycling multidose nasal spray pump for nasal saline and other over-the-counter pharma
The health insurer’s national formulary considers Amylyx Pharmaceuticals’ Relyvrio to be “experimental, investigational or unproven for any use,” and now
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
A select assortment of Bristol Myers Squibb’s medicines are headed into orbit where researchers will study the crystallization of the biotherapeutics in microgravity.
A two-chamber setup (TCS) for containment investigations could predict the dustiness of HPAPIs in a sealed system at different flow
Luye Pharma, the international pharmaceutical company, has developed a drug called Rykindo which has been approved by the FDA. This
Pharmaceutical Technology analyses recent trial and regulatory-related announcements that will likely impact therapy manufacturing plans. In this last 2022 edition
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
Pharmaceutical Technology analyses recent trial and regulatory-related announcements that will likely impact therapy manufacturing plans. In this last 2022 edition
Global contract development and manufacturing organisation (CDMO) Recipharm, has bolstered its sterile filling capabilities by investing in Lab+ technology for
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
A two-chamber setup (TCS) for containment investigations could predict the dustiness of HPAPIs in a sealed system at different flow
Aptar Pharma is launching APF Futurity, its first metal-free, designed-for-recycling multidose nasal spray pump for nasal saline and other over-the-counter pharma
Chester Medical has ploughed just under £500,000 CAPEX investment as it continues to grow. With Jenny Dixon who joined Chester
Aptar Pharma, is a pharmaceutical leader in the manufacturing and development of drug delivery systems and solutions. They have launched
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
With just two weeks to go until Connect in Pharma 2023, we sat down with event co-founder Wilfried Phipps to discuss the many features and opportunities attendees can look forward to on 14th-15th June. Wilfried shares his insights into the key themes of the conference agenda and gives his advice about how you can make the most out of your visit.
The biopharmaceutical company Lexicon, have announced the approval of their drug INPEFA™ (sotagliflozin) by the FDA in effort to treatment
Connected health will be one of the topics discussed during the upcoming Connect in Pharma conferences. As experts in this sector, Eric Dessertenne, CEO of Biocorp, and Emre Ozcan, Global Head of Digital Health at Merck, will deliver talks on the challenges that lie ahead in the development of connected devices.
A select assortment of Bristol Myers Squibb’s medicines are headed into orbit where researchers will study the crystallization of the biotherapeutics in microgravity.
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
BD (Becton, Dickinson, and Company) is a leading global medical technology company that focuses on advancing healthcare through improved medical
Insilico Medicine, a company that uses artificial intelligence (AI) for drug discovery and development, has integrated its AI-powered chatbot, “ChatPandaGPT,”
Pfizer and Seagen have announced their merger, where Seagen will be obtained by Pfizer. Seagen is a global biotechnology company
Pharmaceutical Technology analyses recent trial and regulatory-related announcements that will likely impact therapy manufacturing plans. In this last 2022 edition
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
Insilico Medicine, a company that uses artificial intelligence (AI) for drug discovery and development, has integrated its AI-powered chatbot, “ChatPandaGPT,”
FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age The U.S. Food and Drug
1. What do you think will be the biggest trends in the pharmaceutical and biopharmaceutical industry for 2022? • Digitalisation
When daily pills aren’t enough, can advanced medicines help with severe allergic diseases? Small molecule pills are the solution to
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
[COPY HERE]
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
[COPY HERE]
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit
BD (Becton, Dickinson, and Company) is a leading global medical technology company that focuses on advancing healthcare through improved medical
With just two weeks to go until Connect in Pharma 2023, we sat down with event co-founder Wilfried Phipps to discuss the many features and opportunities attendees can look forward to on 14th-15th June. Wilfried shares his insights into the key themes of the conference agenda and gives his advice about how you can make the most out of your visit.
Geneva’s position as a leading European life science hub makes it the ideal choice for Connect in Pharma
The biopharmaceutical company Lexicon, have announced the approval of their drug INPEFA™ (sotagliflozin) by the FDA in effort to treatment
